|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
3.470 +0.030 (+0.872%) | 2024/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | |
| Turnover | 14,273,724 | 10.171% | 27,026,555 | 26,763,016 | 20,577,616 | 15,518,468 |
| Cost of Sales | (10,739,959) | 6.470% | (21,131,234) | (21,061,682) | (16,469,623) | (11,901,219) |
| Gross Profit | 3,533,765 | 23.185% | 5,895,321 | 5,701,334 | 4,107,993 | 3,617,249 |
| 2024/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (21,451) | 161.885% | (5,926) | 11,381 | (45,620) | (38,413) | |
| Profit / (Loss) before Taxation | 821,069 | 70.604% | 939,399 | 550,994 | (252,514) | 401,219 | |
| Taxation | (52,021) | 43.991% | (56,263) | (14,485) | (13,427) | (58,539) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (95) | -- | 341 | (856) | 386 | 5,908 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 768,953 | 72.453% | 883,477 | 535,653 | (265,555) | 348,588 | |
| 2024/09 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | |
| Net Finance Costs / (Income) | (227,543) | 12.725% | (472,061) | (325,755) | (206,023) | (162,966) |
| Depreciation & Amortisation | 26,415 | 4.718% | 53,682 | 63,719 | 60,576 | 39,626 |
| Directors' Emoluments | -- | -- | 32,547 | 22,243 | 27,436 | 26,601 |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | 4.790 | 45.152% | 6.290 | 3.970 | -1.970 | 2.630 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.077 | 0.019 | 0.031 | 0.076 |
| NBV per share ($) | 0.949 | -- | 0.904 | 1.122 | 1.043 | 1.060 |
| Remarks: | Real time quote last updated: 18/12/2024 12:18 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 768,953 |
| %Change | 72.453% |
| EPS / (LPS) | RMB 0.048 |
| NBV Per Share (¥) | RMB 0.949 |